Research Specifications

Home \pH‑responsive nanosystems ...
Title
pH‑responsive nanosystems based on reduced graphene oxide grafted with polycaprolactone‑block‑poly(succinyloxyethylmethacrylate) for doxorubicin release
Type of Research Article
Keywords
Drug delivery · Reduced graphene oxide · PCL · PHEMA · Doxorubicin
Abstract
pH-responsive nanocarriers were synthesized via polycaprolactone-b-poly(succinyloxyethylmethacrylate) copolymers grafted onto reduced graphene oxide (rGO-g-PCL-b-PSEMA) for anticancer drug delivery applications. For this propose, ε-caprolactone monomer was polymerized from –OH groups of rGO with ring-opening polymerization (ROP) to obtain polycaprolactone grafts (rGO-g-PCL). In the next step, 2-hydroxyethylmethacrylate monomer was polymerized from PCL end through atom transfer radical polymerization to aford rGO-g-PCL-b-poly(hydroxyethylmethacrylate) (PHEMA). The pH-responsive rGO-g-PCL-b-PSEMA was obtained by reacting rGO-g-PCL-b-PHEMA with excess succinic anhydride in pyridine under mild conditions. The pH sensitivity of nanosystems was confrmed via dynamic light scattering at pH values of 4 and 7.4. Doxorubicin encapsulation efcacy was calculated to be 92%. The efect of pH on release behaviors of rGOg-PCL-b-PSEMA nanocarriers was investigated. The release rates at pH values of 7.4, 5.4 and 4 were about 52.1, 64.2 and 68.63 wt% after 775 min and at 37 °C. The release rate was improved at tumor simulated environment (42 °C and pH ≤ 5.4). The cytotoxic efects of nanosystems were appraised by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, and the results indicated that novel smart nanosystems were nontoxic to MCF-7 cells and can be applied as anticancer drug delivery systems.
Researchers Bakhshali Massoumi (First Researcher)، Raana Sarvari (Second Researcher)، Leila Khanizadeh (Third Researcher)، Samira Agbolaghi (Fourth Researcher)، Younes Beygi khosrowshahi (Fifth Researcher)